Concepedia

Publication | Closed Access

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

47

Citations

32

References

2013

Year

Abstract

To our knowledge, we report for the first time the feasibility and T-cell immunogenicity of WT1 mRNA-loaded DC immunotherapy in ovarian cancer.

References

YearCitations

Page 1